New survey by the harris poll highlights gaps in cervical cancer screening access

Survey conducted in the us, uk and sweden exposes lack of education on options and unclear guidance on hpv testing franklin lakes, n.j. , jan. 10, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced the results of a harris poll survey of women in the u.s., u.k. and sweden, which shines a spotlight on the differences in access to cervical cancer screening and prevention.
BDX Ratings Summary
BDX Quant Ranking